These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 24048493)
1. Effects of antihypertensive drugs on central blood pressure: new evidence, more challenges. Pucci G; Battista F; Schillaci G Hypertens Res; 2014 Jan; 37(1):10-2. PubMed ID: 24048493 [No Abstract] [Full Text] [Related]
2. Is validation of non-invasive hemodynamic measurement devices actually required? Salvi P Hypertens Res; 2014 Jan; 37(1):7-9. PubMed ID: 24048491 [No Abstract] [Full Text] [Related]
3. Efficacy of losartan and carvedilol on central hemodynamics in hypertensives: a prospective, randomized, open, blinded end point, multicenter study. Kim EJ; Song WH; Lee JU; Shin MS; Lee S; Kim BO; Hong KS; Han SW; Park CG; Seo HS Hypertens Res; 2014 Jan; 37(1):50-6. PubMed ID: 24026037 [TBL] [Abstract][Full Text] [Related]
4. [Effect of antihypertensive drugs of various pharmacological groups on reaction of arterial pressure under conditions of stree testing. Part II. Value of various strategies of potentiation of systemic vasodilatation]. Praskurnichiĭ EA; Shevchenko OP; Makarova SV; Zhukova VA; Savel'eva SA Kardiologiia; 2008; 48(4):18-24. PubMed ID: 18447835 [No Abstract] [Full Text] [Related]
6. Food and Drug Administration: Cardiovascular and Renal Drugs Advisory Committee, 98th meeting, January 6th-7th, 2003. Fleming T; Borer J; Armstrong PW; Pfeffer M; Circulation; 2003 Jan; 107(2):e9002-3. PubMed ID: 12538443 [No Abstract] [Full Text] [Related]
7. Three-dimensional echocardiographic and magnetic resonance assessment of the effect of telmisartan compared with carvedilol on left ventricular mass a multicenter, randomized, longitudinal study. Galzerano D; Tammaro P; del Viscovo L; Lama D; Galzerano A; Breglio R; Tuccillo B; Paolisso G; Capogrosso P Am J Hypertens; 2005 Dec; 18(12 Pt 1):1563-9. PubMed ID: 16364826 [TBL] [Abstract][Full Text] [Related]
8. [Balanced beta--alpha-blocker treatment with carvedilol in mild-moderate arterial hypertension]. Perocchio M; Gigli G; Barra M; Sacchetti R; Vallebona A; Rosolen GA; Orlandi S Minerva Cardioangiol; 1996 Mar; 44(3):115-21. PubMed ID: 8767610 [TBL] [Abstract][Full Text] [Related]
9. Influence of salt intake on the antihypertensive effect of carvedilol. Ruilope LM; Lahera V J Hypertens Suppl; 1993 Jun; 11(4):S17-9. PubMed ID: 8104238 [TBL] [Abstract][Full Text] [Related]
10. Ventricular hypertrophy and hypertension: prognostic elements and implications for management. Krauser DG; Devereux RB Herz; 2006 Jun; 31(4):305-16. PubMed ID: 16810470 [TBL] [Abstract][Full Text] [Related]
16. Beta-blockers for hypertension: are they going out of style? Che Q; Schreiber MJ; Rafey MA Cleve Clin J Med; 2009 Sep; 76(9):533-42. PubMed ID: 19726558 [TBL] [Abstract][Full Text] [Related]
17. Carvedilol outclasses the other beta-blockers. Cardiovasc J S Afr; 2001; 12(2):120-1. PubMed ID: 11474696 [No Abstract] [Full Text] [Related]
19. [Beta-adrenoblockers for the correction of arterial hypertension in postmenopausal women]. Latfullin IA; Ishmurzin GP; Gaĭfullina RF; Akhmerova RI; Kim ZF; Podol'skaia AA Klin Med (Mosk); 2010; 88(2):68-71. PubMed ID: 21105477 [TBL] [Abstract][Full Text] [Related]